Thursday, July 30, 2026

HomeBusiness NewsPfizer will dominate $28 billion COVID-pill market in 2022, analysis shows

Pfizer will dominate $28 billion COVID-pill market in 2022, analysis shows

- Advertisement -


Pfizer’s goal is to deliver its oral antiviral therapy to patients most in need as soon as possible and at an affordable price, subject to country regulatory authorisation, spokeswoman Sharon Castillo said in an email. Merck didn’t immediately respond to a request for comment.

Some…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed